Open Access Critical Evidence Review

Carbohydrate restriction and metabolism in type 2 diabetes: metabolic and hormonal effects

In the 28 patients with type 2 diabetes, six weeks of a low carb diet reduced postprandial and daily glycemia, insulin secretion, and proinsulin, while improving beta-cell function indices and satiety. Gastric slowing is documented; an increase in incretins is not. Independent confirmation remains limited, especially in the long term.

Cite this article
Moscati, M. (2026). Carbohydrate restriction and metabolism in type 2 diabetes: metabolic and hormonal effects. Life Science Hub Journal. DOI: 10.5281/zenodo.24204850. https://lifesciencehub.info/en/carbohydrate-restriction-and-metabolism-in-type-2-diabetes-metabolic-and-hormonal-effects
LIFE Science Hub - Journal of Science · 2026 / Nov

DOI 10.5281/zenodo.24204850

Article history
Dates
  • Published 11/11/2026
  • Updated 13/11/2026
Revisions
  1. v1.0 — 11/11/2026 Initial publication of the article.
  2. v1.1 — 13/11/2026 Editorial update of content, sources or references.

LIFE Science Hub keeps a record of every published version of the article to ensure editorial transparency. Future revisions will appear here.

Scientific composition with low carb foods, subtle symbols of glucose and pancreas, to illustrate the metabolic response in type 2 diabetes.
Low carb diet and more stable glycemic response in type 2 diabetes, with lower insulin secretion and greater satiety.

ABSTRACT

The analyzed study evaluated whether six weeks of a diet with a lower carbohydrate intake and a higher protein intake could modify the meal response in 28 people with type 2 diabetes. Compared to a conventional diabetes diet, the regimen with 30% of energy from carbohydrates reduced post-meal glycemic excursion by 60% and 24-hour average glycemia by 13%. Postprandial insulin secretion and certain markers of proinsulin processing also decreased, while indirect indices of pancreatic beta-cell response improved.

The publication contributes to the narrative of "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi, according to which a moderate carbohydrate restriction can make the glycemic response more gradual, reduce insulin requirements, and increase satiety. A slowing of gastric emptying was observed, but the abstract does not document an increase in incretins: GIP decreased, and GLP-1, peptide YY, and cholecystokinin did not change significantly. Independent trials and meta-analysis confirm, above all, the short-term improvement in glycemia and certain indices of beta-cell function; long-term evidence is less clear-cut. The conclusion is therefore moderately supported, but requires larger and more prolonged studies.

Analyzed study

Effects of carbohydrate restriction on postprandial glucose metabolism, b-cell function, gut hormone secretion, and satiety in patients with Type 2 diabetes

Skytte MJ, Samkani A, Astrup A, Frystyk J, Rehfeld JF, Holst JJ, Madsbad S, Burling K, Fenger M, Thomsen MN, Larsen TM, Krarup T, Haugaard SB

American journal of physiology. Endocrinology and metabolism, 2021

DOI: 10.1152/ajpendo.00165.2020

PMID: 33103448

The research question was whether a moderate reduction in carbohydrates, compensated by more protein and fat, would change how the body manages glucose after meals in people with type 2 diabetes. The hypothesis was that a lower carbohydrate intake would reduce glycemic variability and lighten the secretory workload of pancreatic beta cells, which are the cells that produce insulin.

The reason for the citation in paragraph 2.3 and paragraph 14.4 of “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi is specific: the study documents that, in an isocaloric dietary comparison, reducing the carbohydrate portion can lower the post-meal glucose spike, reduce average 24-hour glycemia, decrease postprandial insulin secretion, and increase satiety.

The research can demonstrate metabolic differences observed in the short term, under controlled dietary conditions, between the two dietary regimens. However, it cannot prove that the diet prevents pancreatic deterioration in the long term, that it reduces diabetes complications, or that the effects are identical in all people with type 2 diabetes.

Materials and methods of the original study

The study used a randomized crossover design: the same participants followed both dietary regimens in separate periods. Twenty-eight people with type 2 diabetes, with an average glycated hemoglobin of 60 mmol/mol, were assigned in random order to six weeks of a low carb, high-protein diet, followed by six weeks of a conventional diabetes diet, or in the reverse sequence.

The carbohydrate-restricted diet provided 30% of energy from carbohydrates, 30% from protein, and 40% from fat. The conventional diet provided 50%, 17%, and 33%, respectively. The available material does not report the washout period between the two interventions, the full inclusion and exclusion criteria, or the details of the statistical analyses.

The researchers used continuous glucose monitoring—a sensor that repeatedly records glycemia throughout the day—and mixed-meal tests. They measured glycemia, insulin secretion, several indicators of beta-cell function, glucagon, and gut hormones. Gastric emptying, which is the speed at which stomach contents reach the intestine, was estimated through post-meal paracetamol concentrations. Satiety was assessed using visual scales completed by the participants.

Results

The most immediate result for the reader is that, after six weeks, the low carb regimen produced significantly lower glycemic spikes after meals. The net area under the postprandial glucose curve, a measure of overall glucose exposure after a meal, was reduced by 60% compared to the conventional diet (P < 0.001). The average 24-hour glycemia, recorded by the sensor, also decreased by 13% (P < 0.001).

The low carb diet also reduced the post-meal insulin secretion rate by 24% (P = 0.015). This data indicates that a lower secretion of insulin was required to manage a smaller amount of available glucose after the meal; it does not, by itself, demonstrate a permanent recovery of pancreatic function. Fasting concentrations of intact proinsulin and 32,33-split proinsulin also decreased; these are markers that, when elevated, can reflect less efficient processing of the hormone.

Two estimated indices of beta-cell function improved: the insulinogenic index, which describes the early insulin response to glucose, increased by 31%, while beta-cell sensitivity to glucose increased by 45%; for both, P < 0.001. Postprandial glucagon, on the other hand, increased by 235% (P < 0.001), an effect that requires cautious interpretation because glucagon tends to increase hepatic glucose production.

Regarding gastrointestinal mechanisms, gastric emptying was delayed by 15 minutes (P < 0.001) and subjective satiety increased by 18% (P = 0.03). GIP, an incretin gut hormone that can promote insulin secretion, decreased by 29% (P < 0.001). No significant differences emerged for GLP-1, total peptide YY, or cholecystokinin. Consequently, the result does not support the idea of a general increase in incretins during this specific intervention.

Interpretation

Overall, the study suggests that a lower intake of carbohydrates limits the amount of glucose that rapidly enters the bloodstream after meals. This change is consistent with a reduction in glycemic spikes and a lower insulin secretion required to manage them. The improvement in beta-cell function indices and proinsulin processing markers is compatible with a more efficient pancreatic response in the studied context.

The segment of the narrative chain actually documented is: lower carbohydrate availability in the meal → lower postprandial glycemic excursion and lower 24-hour glycemia → lower postprandial insulin secretion, with an improvement in some estimated indices of beta-cell function. Delayed gastric emptying represents an additional plausible mechanism that can distribute glucose absorption more gradually.

However, the interpretation must remain proportionate to the data. The study does not prove that the pancreas was "protected" in the long term, nor that chronic glucotoxicity has decreased, which would require prolonged measurements and clinical outcomes. Furthermore, the statement in the book regarding increased incretin secretion must be contextualized: in the analyzed study, GIP decreased, and the responses of GLP-1, peptide YY, and cholecystokinin did not show significant variations.

Independent confirming evidence

Direct confirmation of the passage regarding beta-cell function comes from an independent 12-week randomized trial conducted in 57 adults with type 2 diabetes not treated with insulin. With equal energy intake, a diet with approximately 9% of energy from carbohydrates was compared to a 55% carbohydrate diet. The early C-peptide response to glucose, an indicator of initial insulin secretion, was approximately doubled with the low carb diet; the maximal response was 22% higher, and the disposition index, which integrates insulin secretion and insulin sensitivity, increased by 32% [1]. The study is relevant because it uses robust dynamic measures, but it remains limited to twelve weeks and to people with relatively mild diabetes.

A second independent crossover study helps clarify the possible gastrointestinal contribution. Eight people with type 2 diabetes consumed a portion of whey protein before a carbohydrate-rich meal. Gastric emptying was slower, and incremental glucose exposure was lower compared to the meal without protein. Insulin, GIP, and cholecystokinin also increased; GLP-1 was highest when proteins were consumed before the meal [2]. This does not replicate the diet of the original study, nor does it prove that all effects depend on incretins, but it confirms in a biologically consistent way that proteins and gastric emptying can contribute to attenuating postprandial glycemia.

On a larger scale, a meta-analysis of ten randomized trials and 1,376 participants with type 2 diabetes found, within the first year, an average glycated hemoglobin 0.34 percentage points lower with low or moderate carb diets compared to higher carbohydrate diets. Greater carbohydrate restriction was associated with a greater reduction in glycemia [3]. This synthesis confirms the direction of the effect on glycemia, but does not allow for attributing the benefit exclusively to the lower amount of carbohydrates: proteins, fats, diet quality, medications, and adherence also changed.

Conflicting evidence

Conflicting evidence primarily concerns the duration of the effect, not the fact that a reduction in carbohydrates can attenuate glycemic spikes in the short term. A 2024 meta-analysis included six randomized trials with interventions lasting longer than twelve months and found no significant difference in glycated hemoglobin between low-carb diets and control diets: standardized mean difference −0.11, 95% confidence interval from −0.33 to 0.11; P = 0.32. No significant differences emerged for weight, blood pressure, or LDL cholesterol either [4].

This evidence does not directly contradict the acute or six-week results of the analyzed study, as it evaluates a different time horizon and different outcomes. However, it reduces the certainty that the initial glycemic advantage automatically persists in the long term. Differences between studies may depend on the definition of “low carb,” the composition of replacement nutrients, adherence, adjustments to pharmacological therapy, and the baseline characteristics of the participants.

Summary table of evidence

The table distinguishes the data from the publication subject to the review from independent confirmations and the main conflicting evidence regarding the duration of the glycemic effect.

Reference Study type Population or model Main result Direction of evidence Strength of evidence
Original study Randomized crossover trial 28 people with type 2 diabetes; six weeks per diet 60% reduction in postprandial glycemic excursion and 13% in 24-hour glycemia; lower insulin secretion and greater satiety direct confirmation moderate
[1] Isocaloric RCT 57 adults with type 2 diabetes; 12 weeks Diet with approximately 9% energy from carbohydrates increased early C-peptide response and disposition index direct confirmation moderate
[2] Experimental crossover study 8 people with diet-controlled type 2 diabetes A protein preload slowed gastric emptying and reduced postprandial glycemia biologically consistent evidence low
[3] Systematic review and meta-analysis of RCTs 10 trials; 1,376 people with type 2 diabetes Within one year, glycated hemoglobin was 0.34 percentage points lower with lower carbohydrate intake indirect confirmation moderate
[4] Systematic review and meta-analysis of RCTs 6 trials with duration longer than 12 months in adults with type 2 diabetes No significant difference in glycated hemoglobin between low carb diet and controls discordant evidence moderate

Confirmation of the evidence

Claim in the book

In the analyzed paragraphs, "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi states that a moderate reduction in carbohydrates, accompanied by an increase in high-quality proteins and fats, can reduce glycemic excursions, decrease the necessary insulin secretion, improve beta-cell function, and increase satiety. The second paragraph adds that digestive and hormonal changes may contribute to a more gradual glycemic response.

Reduction of carbohydrates → less glucose available after the meal → lower glycemic spikes and lower insulin secretion → improvement of beta-cell function indices and greater satiety

The publication subject to the Evidence Review was used in the book to support the following passage: an isocaloric diet with a lower carbohydrate intake can rapidly reduce postprandial glycemic excursions and average daily glycemia, require lower insulin secretion, improve certain indices of beta-cell response, slow gastric emptying, and increase satiety.

The correspondence between the study and the narrative is clear regarding the glycemic, insulin, and satiety components. The original trial directly measured a reduction in glycemic spikes, 24-hour glycemia, and insulin secretion, along with an improvement in beta-cell function indicators. An independent RCT subsequently confirmed, in a different population and using dynamic C-peptide secretion measurements, an improvement in the beta-cell response to glucose with carbohydrate restriction [1].

The slowing of gastric emptying observed in the original study is biologically consistent with independent experimental data: greater protein availability before a carbohydrate-rich meal slowed the exit of food from the stomach and reduced postprandial glycemic exposure [2]. However, the hormonal mechanism is not entirely overlapping. In the original trial, there was no significant increase in GLP-1, peptide YY, or cholecystokinin, while GIP decreased. Therefore, the book's claim regarding increased incretin secretion is not directly confirmed by this publication.

Meta-analyses reinforce the general direction of the narrative in the short term: low carb diets showed an average improvement in glycated hemoglobin within the first year [3]. However, the synthesis of trials lasting over twelve months did not find significant superiority in glycemia compared to control diets [4]. The body of evidence therefore primarily supports postprandial and short-term effects, while it does not allow for the automatic assumption that all benefits persist in the long term.

Overall level of confirmation

MODERATE CONFIRMATION

The central point is directly supported by the original trial and independent human studies that confirm the improvement in beta-cell response, postprandial glycemia, and the potential contribution of gastric emptying. The confirmation is moderate because the sample sizes are small, the interventions are short, and long-term results on glycemia are not consistent.

Conclusions

The study analyzed shows that six weeks of a diet with 30% of energy from carbohydrates, compared to a conventional diet higher in carbohydrates, substantially reduced post-meal glycemic spikes and average daily glycemia in people with type 2 diabetes. The lower postprandial insulin secretion, the improvement in certain beta-cell indices, and increased satiety are consistent with a lower immediate metabolic load.

Independent evidence moderately confirms that carbohydrate restriction can improve short-term glycemic control and certain aspects of the pancreatic response. The slowing of gastric emptying is a plausible and experimentally supported mechanism. However, it is not correct to extend these data to a generalized increase in incretins, nor to infer pancreatic protection or certain long-term glycemic superiority. The sustainability of the dietary pattern, the quality of substitute nutrients, and the adjustment of therapy remain essential elements to be evaluated on an individual basis.

Overall assessment

The narrative regarding lower glycemic spikes, reduced insulin demand, and increased satiety is moderately supported by human trials and a synthesis of randomized studies. The improvement in beta-cell function is promising but still based on short-term interventions. The hypothesis of increased incretins is not confirmed by the original study.

References

[1] Effects of a Carbohydrate-Restricted Diet on b-Cell Response in Adults With Type 2 Diabetes

Gower BA, Goss AM, Yurchishin ML, Deemer SE, Sunil B, Garvey WT, 2025

The Journal of Clinical Endocrinology & Metabolism

[2] Effects of a Protein Preload on Gastric Emptying, Glycemia, and Gut Hormones After a Carbohydrate Meal in Diet-Controlled Type 2 Diabetes

Ma J, Stevens JE, Cukier K, Maddox AF, Wishart JM, Jones KL, et al., 2009

Diabetes Care

[3] Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes

Snorgaard O, Poulsen GM, Andersen HK, Astrup A, 2017

BMJ Open Diabetes Research & Care

[4] Efficacy of long‐term low carbohydrate diets for patients with type 2 diabetes: A systematic review and meta‐analysis

Ichikawa T, Okada H, Hironaka J, Nakajima H, Okamura T, Majima S, et al., 2024

Journal of Diabetes Investigation

Editorial note

Artificial Intelligence was used solely as a tool to support editorial and documentary work. All content, interpretations, bibliographic citations and conclusions have been verified, reviewed and approved by the author, who assumes full scientific responsibility for them.

The manuscript was also subject to independent peer review prior to publication.

To ensure maximum transparency, the article's complete history — including the dates of submission, review, acceptance and publication, as well as information on the peer review process — is available on the dedicated Article History page.